Annals ofTransplants

Volume: 3 - Number: 22 - September 15, 2005

Outstanding

Choices aplenty: antifungal prophylaxis in hematopoietic stem cell transplant recipients

Tacrolimus as monotherapy or combined with minidose methotrexate for graft-versus-host disease prophylaxis after allogeneic peripheral blood stem cell transplantation: long-term outcomes

Bone metabolism in patients more than five years after bone marrow transplantation

Single agent dexamethasone for pre-stem cell transplant induction therapy for multiple myeloma

Antimicrobials Post Transplant

A pilot study of targeted itraconazole prophylaxis in patients with graft-versus-host disease at high risk of invasive mould infections following allogeneic stem cell transplantation

Breast Cancer

HER2 overexpression as a prognostic factor in metastatic breast cancer patients treated with high-dose chemotherapy and autologous stem cell support

Adoptive immunotherapy with donor lymphocyte infusions and interleukin-2 after high-dose therapy and autologous stem cell rescue for multiple myeloma

Effects of ATG

Assessment of the coagulation profile in hemato-oncological patients receiving ATG-based conditioning treatment for allogeneic stem cell transplantation

Graft Versus Tumor Effects

Donor leukocyte infusions in relapsed Hodgkin's lymphoma following allogeneic stem cell transplantation: CD3+ cell dose, GVHD and disease response

Evidence for a graft-versus-mast-cell effect after allogeneic bone marrow transplantation

Graft-versus-lymphoma effect in refractory cutaneous T-cell lymphoma after reduced-intensity HLA-matched sibling allogeneic stem cell transplantation

Graft-Versus-Host Disease

Tacrolimus as monotherapy or combined with minidose methotrexate for graft-versus-host disease prophylaxis after allogeneic peripheral blood stem cell transplantation: long-term outcomes

Risk assessment and outcome of chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell transplantation in pediatric patients

Non-Myeloablative Stem Cell Transplants

Reduced-intensity conditioning prior to allogeneic transplantation of hematopoietic stem cells: the need for T cells early after transplantation to induce a graft-versus-lymphoma effect

Post-Transplant Complications

Immunological and electrophysiological investigations of severe ptosis after bone marrow transplantation

Bone metabolism in patients more than five years after bone marrow transplantation

Infectious complications and outcomes after allogeneic hematopoietic stem cell transplantation in Korea

Post-Transplant Complications

Frequent severe liver iron overload after stem cell transplantation and its possible association with invasive aspergillosis

High-dose treosulfan in patients with relapsed or refractory high-grade lymphoma receiving tandem autologous blood stem cell transplantation

Single agent dexamethasone for pre-stem cell transplant induction therapy for multiple myeloma

Progenitor Cell Mobilisation

A randomised study comparing peripheral blood progenitor mobilisation using intermediate-dose cyclophosphamide plus lenograstim with lenograstim alone

Review

Choices aplenty: antifungal prophylaxis in hematopoietic stem cell transplant recipients

Sickle Cell Disease

Transplantation of unrelated placental blood cells in children with high-risk sickle cell disease

Telomere Length

Telomere length predicts neutrophil recovery in the absence of G-CSF after autologous peripheral blood stem cell transplantation